Home › Kidney Diseases › California › Los Angeles
Kidney Diseases clinical trials in Los Angeles, CA
4 studies for Kidney Diseases are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
RecruitingPhase 3
- Academic Medical Research Institute, Los Angeles
- UCLA University of California Los Angeles, Los Angeles
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
RecruitingPhase 3
- Academic Medical Research Institute, Los Angeles
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
RecruitingObservational study
- Keck Medical Center of USC, Los Angeles
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
RecruitingPhase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
About Kidney Diseases
Properly functioning kidneys are critical for maintaining good health. Diabetes, high blood pressure, or family history can increase risk of kidney disease.
More about Kidney Diseases on MedlinePlus
Kidney Diseases trials in other cities
- Atlanta, GA11 studies
- Houston, TX8 studies
- Orlando, FL7 studies
- Miami, FL6 studies
- New York City, NY5 studies
- Durham, NC5 studies
- Philadelphia, PA5 studies
- Dallas, TX5 studies
- Cedar Rapids, IA4 studies
- Winston-Salem, NC4 studies
- Boston, MA4 studies
- Washington, DC4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.